Lupus Nephritis
Lupus nephritis is a complication of systemic lupus erythematosus (SLE) that causes inflammation in the kidneys, potentially leading to kidney damage. It can affect how well your kidneys filter waste from your blood.
Lupus Nephritis: KYV-101 CAR T-Cell Therapy
We are testing a new immune cell therapy for individuals with refractory lupus nephritis. The goal is to see if it can improve kidney function in patients who have not responded to other treatments.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Charite Universitaetsmedizin Berlin KöR
Medical Clinic with focus on Rheumatology and Clinical Immunology, Department of New Therapies
Berlin, Germany
Technische Universitaet Dresden
Medical Clinic and Polyclinic III
Dresden, Germany
Universitaetsklinikum Duesseldorf AöR
Clinic for Rheumatology
Düsseldorf, Germany
Sponsor: Kyverna Therapeutics Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.